出版应用/物种/样本/稀释 | 参考文献 |
---|
| Zhang X, Huang Z, Wang J, Ma Z, Yang J, Corey E, et al. Targeting Feedforward Loops Formed by Nuclear Receptor RORγ and Kinase PBK in mCRPC with Hyperactive AR Signaling. Cancers (Basel). 2021;13: pubmed 出版商
|
| Lenting K, van den Heuvel C, van Ewijk A, Elmelik D, de Boer R, Tindall E, et al. Mapping actionable pathways and mutations in brain tumours using targeted RNA next generation sequencing. Acta Neuropathol Commun. 2019;7:185 pubmed 出版商
|
| Li N, Truong S, Nouri M, Moore J, Al Nakouzi N, Lubik A, et al. Non-canonical activation of hedgehog in prostate cancer cells mediated by the interaction of transcriptionally active androgen receptor proteins with Gli3. Oncogene. 2018;37:2313-2325 pubmed 出版商
|
| White M, Lin C, Rajapakshe K, Dong J, Shi Y, Tsouko E, et al. Glutamine Transporters Are Targets of Multiple Oncogenic Signaling Pathways in Prostate Cancer. Mol Cancer Res. 2017;15:1017-1028 pubmed 出版商
|
| Frank S, Berger P, Ljungman M, Miranti C. Human prostate luminal cell differentiation requires NOTCH3 induction by p38-MAPK and MYC. J Cell Sci. 2017;130:1952-1964 pubmed 出版商
|
| Ashkenazi A, Bento C, Ricketts T, Vicinanza M, Siddiqi F, Pavel M, et al. Polyglutamine tracts regulate beclin 1-dependent autophagy. Nature. 2017;545:108-111 pubmed 出版商
|
- 免疫沉淀; 人类
- 免疫印迹; 人类; 图 1a
- 免疫印迹; 大鼠; 图 3g
- 免疫印迹; 小鼠; 图 s4
| Polanco M, Parodi S, Piol D, Stack C, Chivet M, Contestabile A, et al. Adenylyl cyclase activating polypeptide reduces phosphorylation and toxicity of the polyglutamine-expanded androgen receptor in spinobulbar muscular atrophy. Sci Transl Med. 2016;8:370ra181 pubmed 出版商
|
- 免疫印迹; African green monkey; 图 4c
| Depaolo J, Wang Z, Guo J, Zhang G, Qian C, Zhang H, et al. Acetylation of androgen receptor by ARD1 promotes dissociation from HSP90 complex and prostate tumorigenesis. Oncotarget. 2016;7:71417-71428 pubmed 出版商
|
- 免疫细胞化学; 人类; 1:500; 图 4d
- 免疫印迹; 人类; 图 4a
| Lu H, Wang T, Li J, Fedele C, Liu Q, Zhang J, et al. αvβ6 Integrin Promotes Castrate-Resistant Prostate Cancer through JNK1-Mediated Activation of Androgen Receptor. Cancer Res. 2016;76:5163-74 pubmed 出版商
|
| Bott L, Salomons F, Maric D, Liu Y, Merry D, Fischbeck K, et al. The polyglutamine-expanded androgen receptor responsible for spinal and bulbar muscular atrophy inhibits the APC/C(Cdh1) ubiquitin ligase complex. Sci Rep. 2016;6:27703 pubmed 出版商
|
| Kaushik A, Shojaie A, Panzitt K, Sonavane R, Venghatakrishnan H, Manikkam M, et al. Inhibition of the hexosamine biosynthetic pathway promotes castration-resistant prostate cancer. Nat Commun. 2016;7:11612 pubmed 出版商
|
| Mounir Z, Korn J, Westerling T, Lin F, Kirby C, Schirle M, et al. ERG signaling in prostate cancer is driven through PRMT5-dependent methylation of the Androgen Receptor. elife. 2016;5: pubmed 出版商
|
- 免疫沉淀; 人类; 图 1c
- 免疫细胞化学; 人类; 1:400; 图 1a
| Destouches D, Sader M, Terry S, Marchand C, Maillé P, Soyeux P, et al. Implication of NPM1 phosphorylation and preclinical evaluation of the nucleoprotein antagonist N6L in prostate cancer. Oncotarget. 2016;7:69397-69411 pubmed 出版商
|
| Johnson D, Hooker E, Luong R, Yu E, He Y, Gonzalgo M, et al. Conditional Expression of the Androgen Receptor Increases Susceptibility of Bladder Cancer in Mice. PLoS ONE. 2016;11:e0148851 pubmed 出版商
|
- 免疫沉淀; 人类; 图 8
- 免疫细胞化学; 人类
- 免疫印迹; 人类; 图 5
| Mehraein Ghomi F, Church D, Schreiber C, Weichmann A, Basu H, Wilding G. Inhibitor of p52 NF-κB subunit and androgen receptor (AR) interaction reduces growth of human prostate cancer cells by abrogating nuclear translocation of p52 and phosphorylated AR(ser81). Genes Cancer. 2015;6:428-44 pubmed
|
- 免疫组化-石蜡切片; 人类; 1:100; 图 2
- 免疫印迹; 人类; 图 1
| Hagberg Thulin M, Nilsson M, Thulin P, Céraline J, Ohlsson C, Damber J, et al. Osteoblasts promote castration-resistant prostate cancer by altering intratumoral steroidogenesis. Mol Cell Endocrinol. 2016;422:182-191 pubmed 出版商
|
- 免疫组化-石蜡切片; 小鼠; 图 3
- 免疫组化-石蜡切片; 人类; 图 7
- 染色质免疫沉淀
; 人类; 图 4
- 免疫沉淀; 人类; 图 2
- 免疫印迹; 人类; 图 2
| Qiu M, Fan Q, Zhu Z, Kwan S, Chen L, Chen J, et al. KDM4B and KDM4A promote endometrial cancer progression by regulating androgen receptor, c-myc, and p27kip1. Oncotarget. 2015;6:31702-20 pubmed 出版商
|
| Liu X, Chen X, Rycaj K, Chao H, Deng Q, Jeter C, et al. Systematic dissection of phenotypic, functional, and tumorigenic heterogeneity of human prostate cancer cells. Oncotarget. 2015;6:23959-86 pubmed
|
| Chen S, Okada M, Nakato R, Izumi K, Bando M, Shirahige K. The Deubiquitinating Enzyme USP7 Regulates Androgen Receptor Activity by Modulating Its Binding to Chromatin. J Biol Chem. 2015;290:21713-23 pubmed 出版商
|
| Sun F, Indran I, Zhang Z, Tan M, Li Y, Lim Z, et al. A novel prostate cancer therapeutic strategy using icaritin-activated arylhydrocarbon-receptor to co-target androgen receptor and its splice variants. Carcinogenesis. 2015;36:757-68 pubmed 出版商
|
- 免疫组化-石蜡切片; 人类; 1:500; 图 1
- 免疫印迹; 人类; 1:500; 图 1
| Lee S, Luong R, Johnson D, Cunha G, Rivina L, Gonzalgo M, et al. Androgen signaling is a confounding factor for β-catenin-mediated prostate tumorigenesis. Oncogene. 2016;35:702-14 pubmed 出版商
|
| Toropainen S, Malinen M, Kaikkonen S, Rytinki M, Jääskeläinen T, Sahu B, et al. SUMO ligase PIAS1 functions as a target gene selective androgen receptor coregulator on prostate cancer cell chromatin. Nucleic Acids Res. 2015;43:848-61 pubmed 出版商
|
| Wosnitzer M, Mielnik A, Dabaja A, Robinson B, Schlegel P, Paduch D. Ubiquitin Specific Protease 26 (USP26) expression analysis in human testicular and extragonadal tissues indicates diverse action of USP26 in cell differentiation and tumorigenesis. PLoS ONE. 2014;9:e98638 pubmed 出版商
|
| Qiu M, Bao W, Wang J, Yang T, He X, Liao Y, et al. FOXA1 promotes tumor cell proliferation through AR involving the Notch pathway in endometrial cancer. BMC Cancer. 2014;14:78 pubmed 出版商
|
| Samaan S, Tranchevent L, Dardenne E, Polay Espinoza M, Zonta E, Germann S, et al. The Ddx5 and Ddx17 RNA helicases are cornerstones in the complex regulatory array of steroid hormone-signaling pathways. Nucleic Acids Res. 2014;42:2197-207 pubmed 出版商
|
| Ni M, Chen Y, Fei T, Li D, Lim E, Liu X, et al. Amplitude modulation of androgen signaling by c-MYC. Genes Dev. 2013;27:734-48 pubmed 出版商
|
| Sarkar S, Brautigan D, Parsons S, Larner J. Androgen receptor degradation by the E3 ligase CHIP modulates mitotic arrest in prostate cancer cells. Oncogene. 2014;33:26-33 pubmed 出版商
|
| Hsu F, Yang M, Lin E, Tseng C, Lin H. The significance of Her2 on androgen receptor protein stability in the transition of androgen requirement in prostate cancer cells. Am J Physiol Endocrinol Metab. 2011;300:E902-8 pubmed 出版商
|
| Zhang D, Hu Q, Liu X, Ji Y, Chao H, Liu Y, et al. Intron retention is a hallmark and spliceosome represents a therapeutic vulnerability in aggressive prostate cancer. Nat Commun. 2020;11:2089 pubmed 出版商
|
| Wang J, Yu Q, Qiu Z, Dai T, Wang S, Yang X, et al. The combined effect of epigenetic inhibitors for LSD1 and BRD4 alters prostate cancer growth and invasion. Aging (Albany NY). 2020;12:397-415 pubmed 出版商
|
| Georgescu C, Corbin J, Thibivilliers S, Webb Z, Zhao Y, Koster J, et al. A TMEFF2-regulated cell cycle derived gene signature is prognostic of recurrence risk in prostate cancer. BMC Cancer. 2019;19:423 pubmed 出版商
|
| Kounatidou E, Nakjang S, McCracken S, Dehm S, Robson C, Jones D, et al. A novel CRISPR-engineered prostate cancer cell line defines the AR-V transcriptome and identifies PARP inhibitor sensitivities. Nucleic Acids Res. 2019;47:5634-5647 pubmed 出版商
|
| Bai S, Cao S, Jin L, Kobelski M, Schouest B, Wang X, et al. A positive role of c-Myc in regulating androgen receptor and its splice variants in prostate cancer. Oncogene. 2019;38:4977-4989 pubmed 出版商
|
| Cato L, De Tribolet Hardy J, Lee I, Rottenberg J, Coleman I, Melchers D, et al. ARv7 Represses Tumor-Suppressor Genes in Castration-Resistant Prostate Cancer. Cancer Cell. 2019;35:401-413.e6 pubmed 出版商
|
| Rosati R, Patki M, Chari V, Dakshnamurthy S, McFall T, Saxton J, et al. The Amino-terminal Domain of the Androgen Receptor Co-opts Extracellular Signal-regulated Kinase (ERK) Docking Sites in ELK1 Protein to Induce Sustained Gene Activation That Supports Prostate Cancer Cell Growth. J Biol Chem. 2016;291:25983-25998 pubmed
|
| Uo T, Dvinge H, Sprenger C, Bradley R, Nelson P, Plymate S. Systematic and functional characterization of novel androgen receptor variants arising from alternative splicing in the ligand-binding domain. Oncogene. 2017;36:1440-1450 pubmed 出版商
|
| Hay C, Hunter I, Mackenzie A, McEwan I. An Sp1 Modulated Regulatory Region Unique to Higher Primates Regulates Human Androgen Receptor Promoter Activity in Prostate Cancer Cells. PLoS ONE. 2015;10:e0139990 pubmed 出版商
|
| Chan S, Selth L, Li Y, Nyquist M, Miao L, Bradner J, et al. Targeting chromatin binding regulation of constitutively active AR variants to overcome prostate cancer resistance to endocrine-based therapies. Nucleic Acids Res. 2015;43:5880-97 pubmed 出版商
|
| Hay C, Watt K, Hunter I, Lavery D, Mackenzie A, McEwan I. Negative regulation of the androgen receptor gene through a primate-specific androgen response element present in the 5' UTR. Horm Cancer. 2014;5:299-311 pubmed 出版商
|
| Jin H, Zhao J, Wu L, Kim J, Yu J. Cooperativity and equilibrium with FOXA1 define the androgen receptor transcriptional program. Nat Commun. 2014;5:3972 pubmed 出版商
|
| Liu C, Lou W, Zhu Y, Nadiminty N, Schwartz C, Evans C, et al. Niclosamide inhibits androgen receptor variants expression and overcomes enzalutamide resistance in castration-resistant prostate cancer. Clin Cancer Res. 2014;20:3198-3210 pubmed 出版商
|
| Rico Bautista E, Zhu W, Kitada S, Ganapathy S, Lau E, Krajewski S, et al. Small molecule-induced mitochondrial disruption directs prostate cancer inhibition via UPR signaling. Oncotarget. 2013;4:1212-29 pubmed
|
| Hou X, Li Z, Huang W, Li J, Staiger C, Kuang S, et al. Plk1-dependent microtubule dynamics promotes androgen receptor signaling in prostate cancer. Prostate. 2013;73:1352-63 pubmed 出版商
|
| Tomasicchio M, Avenant C, Du Toit A, Ray R, Hapgood J. The progestin-only contraceptive medroxyprogesterone acetate, but not norethisterone acetate, enhances HIV-1 Vpr-mediated apoptosis in human CD4+ T cells through the glucocorticoid receptor. PLoS ONE. 2013;8:e62895 pubmed 出版商
|
| Patki M, Chari V, Sivakumaran S, Gonit M, Trumbly R, Ratnam M. The ETS domain transcription factor ELK1 directs a critical component of growth signaling by the androgen receptor in prostate cancer cells. J Biol Chem. 2013;288:11047-65 pubmed 出版商
|
| Zhang Z, Sun Y, Cho Y, Chow C, Simons S. PA1 protein, a new competitive decelerator acting at more than one step to impede glucocorticoid receptor-mediated transactivation. J Biol Chem. 2013;288:42-58 pubmed 出版商
|
| Olson B, Johnson L, McNeel D. The androgen receptor: a biologically relevant vaccine target for the treatment of prostate cancer. Cancer Immunol Immunother. 2013;62:585-96 pubmed 出版商
|
| La Montagna R, Caligiuri I, Maranta P, Lucchetti C, Esposito L, Paggi M, et al. Androgen receptor serine 81 mediates Pin1 interaction and activity. Cell Cycle. 2012;11:3415-20 pubmed 出版商
|
| Cherian M, Wilson E, Shapiro D. A competitive inhibitor that reduces recruitment of androgen receptor to androgen-responsive genes. J Biol Chem. 2012;287:23368-80 pubmed 出版商
|
| Chan S, Li Y, Dehm S. Androgen receptor splice variants activate androgen receptor target genes and support aberrant prostate cancer cell growth independent of canonical androgen receptor nuclear localization signal. J Biol Chem. 2012;287:19736-49 pubmed 出版商
|
| Schayek H, Bentov I, Jacob Hirsch J, Yeung C, Khanna C, Helman L, et al. Global methylation analysis identifies PITX2 as an upstream regulator of the androgen receptor and IGF-I receptor genes in prostate cancer. Horm Metab Res. 2012;44:511-9 pubmed 出版商
|
| Hay C, McEwan I. The impact of point mutations in the human androgen receptor: classification of mutations on the basis of transcriptional activity. PLoS ONE. 2012;7:e32514 pubmed 出版商
|
| Garay J, Karakas B, Abukhdeir A, Cosgrove D, Gustin J, Higgins M, et al. The growth response to androgen receptor signaling in ER?-negative human breast cells is dependent on p21 and mediated by MAPK activation. Breast Cancer Res. 2012;14:R27 pubmed
|
| Li X, Zhu C, Tu W, Yang N, Qin H, Sun Z. ZMIZ1 preferably enhances the transcriptional activity of androgen receptor with short polyglutamine tract. PLoS ONE. 2011;6:e25040 pubmed 出版商
|
| Rytinki M, Kaikkonen S, Sutinen P, Palvimo J. Analysis of androgen receptor SUMOylation. Methods Mol Biol. 2011;776:183-97 pubmed 出版商
|
| Zhu C, Luong R, Zhuo M, Johnson D, McKenney J, Cunha G, et al. Conditional expression of the androgen receptor induces oncogenic transformation of the mouse prostate. J Biol Chem. 2011;286:33478-88 pubmed 出版商
|
| Bruno R, Vasaitis T, Gediya L, Purushottamachar P, Godbole A, Ates Alagoz Z, et al. Synthesis and biological evaluations of putative metabolically stable analogs of VN/124-1 (TOK-001): head to head anti-tumor efficacy evaluation of VN/124-1 (TOK-001) and abiraterone in LAPC-4 human prostate cancer xenograft model. Steroids. 2011;76:1268-79 pubmed 出版商
|
| Vieira J, Saraiva K, Barbosa M, Porto R, Cresto J, Peixoto C, et al. Effect of dexamethasone and testosterone treatment on the regulation of insulin-degrading enzyme and cellular changes in ventral rat prostate after castration. Int J Exp Pathol. 2011;92:272-80 pubmed 出版商
|
| Aubé M, Larochelle C, Ayotte P. Differential effects of a complex organochlorine mixture on the proliferation of breast cancer cell lines. Environ Res. 2011;111:337-47 pubmed 出版商
|
| Cai J, Hong Y, Weng C, Tan C, Imperato McGinley J, Zhu Y. Androgen stimulates endothelial cell proliferation via an androgen receptor/VEGF/cyclin A-mediated mechanism. Am J Physiol Heart Circ Physiol. 2011;300:H1210-21 pubmed 出版商
|
| Altintas D, Vlaeminck V, Angelov D, Dimitrov S, Samarut J. Cell cycle regulated expression of NCoR might control cyclic expression of androgen responsive genes in an immortalized prostate cell line. Mol Cell Endocrinol. 2011;332:149-62 pubmed 出版商
|
| Schayek H, Bentov I, Sun S, Plymate S, Werner H. Progression to metastatic stage in a cellular model of prostate cancer is associated with methylation of the androgen receptor gene and transcriptional suppression of the insulin-like growth factor-I receptor gene. Exp Cell Res. 2010;316:1479-88 pubmed 出版商
|
| Metzger E, Imhof A, Patel D, Kahl P, Hoffmeyer K, Friedrichs N, et al. Phosphorylation of histone H3T6 by PKCbeta(I) controls demethylation at histone H3K4. Nature. 2010;464:792-6 pubmed 出版商
|
| Zielinski A, Fong S, Allison J, Kawahara M, Coppe J, Feiler H, et al. The helix-loop-helix Id-1 inhibits PSA expression in prostate cancer cells. Int J Cancer. 2010;126:2490-6 pubmed 出版商
|
| Yamashita H, Takahashi S, Ito Y, Yamashita T, Ando Y, Toyama T, et al. Predictors of response to exemestane as primary endocrine therapy in estrogen receptor-positive breast cancer. Cancer Sci. 2009;100:2028-33 pubmed 出版商
|
| Zhang X, Fournier M, Ware J, Bissell M, Yacoub A, Zehner Z. Inhibition of vimentin or beta1 integrin reverts morphology of prostate tumor cells grown in laminin-rich extracellular matrix gels and reduces tumor growth in vivo. Mol Cancer Ther. 2009;8:499-508 pubmed 出版商
|
| Xu B, Sun Y, Tang G, Xu C, Wang L, Zhang Y, et al. Id-1 expression in androgen-dependent prostate cancer is negatively regulated by androgen through androgen receptor. Cancer Lett. 2009;278:220-229 pubmed 出版商
|
| Vasaitis T, Belosay A, Schayowitz A, Khandelwal A, Chopra P, Gediya L, et al. Androgen receptor inactivation contributes to antitumor efficacy of 17{alpha}-hydroxylase/17,20-lyase inhibitor 3beta-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene in prostate cancer. Mol Cancer Ther. 2008;7:2348-57 pubmed 出版商
|
| Li H, Xu L, Masuda K, Raymundo E, McLeod D, Dobi A, et al. A feedback loop between the androgen receptor and a NEDD4-binding protein, PMEPA1, in prostate cancer cells. J Biol Chem. 2008;283:28988-95 pubmed 出版商
|
| Tam C, Chan K, Liu V, Pang B, Yao K, Shiu S. Melatonin as a negative mitogenic hormonal regulator of human prostate epithelial cell growth: potential mechanisms and clinical significance. J Pineal Res. 2008;45:403-12 pubmed 出版商
|
| Guarino G, Spampinato S. Nandrolone decreases mu opioid receptor expression in SH-SY5Y human neuroblastoma cells. Neuroreport. 2008;19:1131-5 pubmed 出版商
|
| Purushottamachar P, Khandelwal A, Vasaitis T, Bruno R, Gediya L, Njar V. Potent anti-prostate cancer agents derived from a novel androgen receptor down-regulating agent. Bioorg Med Chem. 2008;16:3519-29 pubmed 出版商
|
| Serda R, Bisoffi M, Thompson T, Ji M, Omdahl J, Sillerud L. 1alpha,25-Dihydroxyvitamin D3 down-regulates expression of prostate specific membrane antigen in prostate cancer cells. Prostate. 2008;68:773-83 pubmed 出版商
|
| Alimirah F, Panchanathan R, Chen J, Zhang X, Ho S, Choubey D. Expression of androgen receptor is negatively regulated by p53. Neoplasia. 2007;9:1152-9 pubmed
|
| Plymate S, Haugk K, Coleman I, Woodke L, Vessella R, Nelson P, et al. An antibody targeting the type I insulin-like growth factor receptor enhances the castration-induced response in androgen-dependent prostate cancer. Clin Cancer Res. 2007;13:6429-39 pubmed
|
| Arima T, Enokida H, Kubo H, Kagara I, Matsuda R, Toki K, et al. Nuclear translocation of ADAM-10 contributes to the pathogenesis and progression of human prostate cancer. Cancer Sci. 2007;98:1720-6 pubmed
|
| Tyson D, Inokuchi J, Tsunoda T, Lau A, Ornstein D. Culture requirements of prostatic epithelial cell lines for acinar morphogenesis and lumen formation in vitro: role of extracellular calcium. Prostate. 2007;67:1601-13 pubmed
|
| Monsef N, Helczynski L, Lundwall A, Påhlman S. Localization of immunoreactive HIF-1alpha and HIF-2alpha in neuroendocrine cells of both benign and malignant prostate glands. Prostate. 2007;67:1219-29 pubmed
|
| Palazzolo I, Burnett B, Young J, Brenne P, La Spada A, Fischbeck K, et al. Akt blocks ligand binding and protects against expanded polyglutamine androgen receptor toxicity. Hum Mol Genet. 2007;16:1593-603 pubmed
|
| Klokk T, Kurys P, Elbi C, Nagaich A, Hendarwanto A, Slagsvold T, et al. Ligand-specific dynamics of the androgen receptor at its response element in living cells. Mol Cell Biol. 2007;27:1823-43 pubmed
|
| Kim K, Dobi A, Shaheduzzaman S, Gao C, Masuda K, Li H, et al. Characterization of the androgen receptor in a benign prostate tissue-derived human prostate epithelial cell line: RC-165N/human telomerase reverse transcriptase. Prostate Cancer Prostatic Dis. 2007;10:30-8 pubmed
|
| Mukhopadhyay N, Ferdinand A, Mukhopadhyay L, Cinar B, Lutchman M, Richie J, et al. Unraveling androgen receptor interactomes by an array-based method: discovery of proto-oncoprotein c-Rel as a negative regulator of androgen receptor. Exp Cell Res. 2006;312:3782-95 pubmed
|
| Yin H, Radomska H, Tenen D, Glass J. Down regulation of PSA by C/EBPalpha is associated with loss of AR expression and inhibition of PSA promoter activity in the LNCaP cell line. BMC Cancer. 2006;6:158 pubmed
|
| Sobel R, Wang Y, Sadar M. Molecular analysis and characterization of PrEC, commercially available prostate epithelial cells. In Vitro Cell Dev Biol Anim. 2006;42:33-9 pubmed
|
| Alimirah F, Chen J, Basrawala Z, Xin H, Choubey D. DU-145 and PC-3 human prostate cancer cell lines express androgen receptor: implications for the androgen receptor functions and regulation. FEBS Lett. 2006;580:2294-300 pubmed
|
| Alimirah F, Chen J, Xin H, Choubey D. Androgen receptor auto-regulates its expression by a negative feedback loop through upregulation of IFI16 protein. FEBS Lett. 2006;580:1659-64 pubmed
|
| Tokar E, Ancrile B, Cunha G, Webber M. Stem/progenitor and intermediate cell types and the origin of human prostate cancer. Differentiation. 2005;73:463-73 pubmed
|
| Bernard D, Gil J, Dumont P, Rizzo S, Monte D, Quatannens B, et al. The methyl-CpG-binding protein MECP2 is required for prostate cancer cell growth. Oncogene. 2006;25:1358-66 pubmed
|
| Basrawala Z, Alimirah F, Xin H, Mohideen N, Campbell S, Flanigan R, et al. Androgen receptor levels are increased by interferons in human prostate stromal and epithelial cells. Oncogene. 2006;25:2812-7 pubmed
|
| Ilagan R, Zhang L, Pottratz J, Le K, Salas S, Iyer M, et al. Imaging androgen receptor function during flutamide treatment in the LAPC9 xenograft model. Mol Cancer Ther. 2005;4:1662-9 pubmed
|
| Ray M, Wafa L, Cheng H, Snoek R, Fazli L, Gleave M, et al. Cyclin G-associated kinase: a novel androgen receptor-interacting transcriptional coactivator that is overexpressed in hormone refractory prostate cancer. Int J Cancer. 2006;118:1108-19 pubmed
|
| Tokar E, Webber M. Chemoprevention of prostate cancer by cholecalciferol (vitamin D3): 25-hydroxylase (CYP27A1) in human prostate epithelial cells. Clin Exp Metastasis. 2005;22:265-73 pubmed
|
| Li W, Cavasotto C, Cardozo T, Ha S, Dang T, Taneja S, et al. Androgen receptor mutations identified in prostate cancer and androgen insensitivity syndrome display aberrant ART-27 coactivator function. Mol Endocrinol. 2005;19:2273-82 pubmed
|
| Gu Y, Kim K, Ko D, Srivastava S, Moul J, McLeod D, et al. Androgen and androgen receptor antagonist responsive primary African-American benign prostate epithelial cell line. Anticancer Res. 2005;25:1-8 pubmed
|